AAAAAA

   
Results: 1-9 |
Results: 9
Use of the monoclonal antibody DAKO-ER beta (8D5-1) to measure oestrogen receptor beta in breast cancer cells
Authors: Girdler, F Browell, DA Cunliffe, WJ Shenton, BK Hemming, JD Scorer, P Young, JR Brotherick, I
Citation: F. Girdler et al., Use of the monoclonal antibody DAKO-ER beta (8D5-1) to measure oestrogen receptor beta in breast cancer cells, CYTOMETRY, 45(1), 2001, pp. 65-72
MUC1 expression in primary breast cancer: the effect of tamoxifen treatment
Authors: Hanson, JM Browell, DA Cunliffe, WJ Varma, J Allen, A Hemming, D Shenton, BK Young, JR Higgs, MJ Brotherick, I Pearson, JP
Citation: Jm. Hanson et al., MUC1 expression in primary breast cancer: the effect of tamoxifen treatment, BREAST CANC, 67(3), 2001, pp. 215-222
ARMS (TM) allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast
Authors: Hodgson, DR Clayton, SJ Girdler, F Brotherick, I Shenton, B Browell, D Stuart, M Fox, JC Ceuppens, P Foy, CA Whitcombe, D Gibson, NJ
Citation: Dr. Hodgson et al., ARMS (TM) allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast, CLIN CHEM, 47(4), 2001, pp. 774-778
The oestrogen receptors (ER alpha and ER beta) and their role in breast cancer: a review
Authors: Girdler, F Brotherick, I
Citation: F. Girdler et I. Brotherick, The oestrogen receptors (ER alpha and ER beta) and their role in breast cancer: a review, BREAST, 9(4), 2000, pp. 194-200
The impact of transurethral resection of bladder tumour on serum levels ofsoluble E-cadherin
Authors: Durkan, GC Brotherick, I Mellon, JK
Citation: Gc. Durkan et al., The impact of transurethral resection of bladder tumour on serum levels ofsoluble E-cadherin, BJU INT, 83(4), 1999, pp. 424-428
Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer
Authors: Watson, DS Brotherick, I Shenton, BK Wilson, RG Angus, B Varma, JS Campbell, FC
Citation: Ds. Watson et al., Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer, ONCOL-BASEL, 56(1), 1999, pp. 66-72
Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls
Authors: Cook, DB Bustaman, AA Brotherick, I Shenton, BK Self, CH
Citation: Db. Cook et al., Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls, CLIN CHEM, 45(2), 1999, pp. 292-295
Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study
Authors: Karat, D Brotherick, I Shenton, BK Scott, D Raimes, SA Griffin, SM
Citation: D. Karat et al., Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study, BR J CANC, 80(8), 1999, pp. 1271-1274
Growth dysregulation and p53 accumulation in human primary colorectal cancer
Authors: Watson, DS Brotherick, I Shenton, BK Wilson, RG Campbell, FC
Citation: Ds. Watson et al., Growth dysregulation and p53 accumulation in human primary colorectal cancer, BR J CANC, 80(7), 1999, pp. 1062-1068
Risultati: 1-9 |